Intuitive Surgical Company Profile (NASDAQ:ISRG)

About Intuitive Surgical (ISRG)

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ISRG
  • CUSIP: 46120E60
Key Metrics:
  • Previous Close: $822.18
  • 50 Day Moving Average: $758.44
  • 200 Day Moving Average: $694.87
  • 52-Week Range: $610.71 - $824.03
  • Trailing P/E Ratio: 41.45
  • Foreward P/E Ratio: 30.38
  • P/E Growth: 3.11
  • Market Cap: $30.29B
  • Outstanding Shares: 36,840,000
  • Beta: 0.55
  • Net Margins: 27.21%
  • Return on Equity: 14.24%
  • Return on Assets: 12.74%
  • Current Ratio: 5.45%
  • Quick Ratio: 5.14%

Analyst Ratings

Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $793.42 (3.50% downside)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/24/2017WedbushReiterated RatingBuy$875.00LowView Rating Details
4/22/2017Leerink SwannReiterated RatingOutperform$840.00 -> $850.00LowView Rating Details
4/22/2017Citigroup IncReiterated RatingBuy$820.00 -> $917.00LowView Rating Details
4/20/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
4/19/2017Stifel NicolausBoost Price TargetBuy$800.00 -> $850.00LowView Rating Details
4/19/2017Evercore ISIBoost Price TargetIn-Line$750.00 -> $785.00LowView Rating Details
4/19/2017Canaccord GenuityReiterated RatingBuy$800.00 -> $870.00MediumView Rating Details
4/19/2017Barclays PLCReiterated RatingBuy$800.00 -> $830.00HighView Rating Details
4/17/2017Royal Bank of CanadaBoost Price TargetSector Perform -> Sector Perform$720.00 -> $770.00MediumView Rating Details
2/14/2017Bank of America CorpSet Price TargetBuy$770.00 -> $800.00N/AView Rating Details
10/13/2016Wells Fargo & CoInitiated CoverageOutperformN/AView Rating Details
9/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformN/AView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$600.00N/AView Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$610.00 -> $700.00N/AView Rating Details
6/2/2016Goldman Sachs Group IncDowngradeBuy -> Neutral$633.00 -> $674.00N/AView Rating Details
4/20/2016Morgan StanleyReiterated RatingBuyN/AView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
1/22/2016William BlairReiterated RatingBuyN/AView Rating Details
7/22/2015Jefferies Group LLCBoost Price TargetBuy$616.00 -> $675.00N/AView Rating Details
(Data available from 4/24/2015 forward)


Earnings History for Intuitive Surgical (NASDAQ:ISRG)
Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Earnings History by Quarter for Intuitive Surgical (NASDAQ:ISRG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/18/2017Q1 17$3.97$5.09$664.72 million$674.20 millionViewN/AView Earnings Details
1/24/2017Q416$5.99$6.09$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$5.13$6.19$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$4.97$5.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$4.33$4.42$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$5.04$5.89$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$4.23$5.24$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$3.98$4.57$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$2.85$3.57$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$3.43$4.18$599.17 million$604.70 millionViewListenView Earnings Details
10/21/2014Q314$2.68$3.92$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$2.76$2.77$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$3.34$2.67$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$3.81$4.28$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$3.40$3.99$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$4.04$3.90$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$4.02$4.56$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$4.02$4.25$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$3.51$4.46ViewN/AView Earnings Details
7/19/2012$3.57$3.75ViewN/AView Earnings Details
4/17/2012$3.15$3.50ViewN/AView Earnings Details
1/19/2012$3.35$3.75ViewN/AView Earnings Details
10/18/2011$2.81$3.05ViewN/AView Earnings Details
7/19/2011$2.71$2.91ViewN/AView Earnings Details
4/19/2011$2.49$2.59ViewN/AView Earnings Details
1/20/2011$2.25$3.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
2017 EPS Consensus Estimate: $19.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$5.68$5.68$5.68
(Data provided by Zacks Investment Research)


Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ:ISRG)
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 91.16%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/21/2017David J. RosaEVPSell5,000$810.52$4,052,600.00View SEC Filing  
4/21/2017Gary S GuthartCEOSell18,775$810.33$15,213,945.75View SEC Filing  
4/21/2017Jamie SamathVPSell490$811.67$397,718.30View SEC Filing  
4/21/2017Lonnie M SmithDirectorSell3,000$810.12$2,430,360.00View SEC Filing  
3/15/2017Amal M JohnsonDirectorSell1,000$750.00$750,000.00View SEC Filing  
3/15/2017David J RosaEVPSell5,000$750.00$3,750,000.00View SEC Filing  
3/15/2017Jamie SamathVPSell4,268$750.00$3,201,000.00View SEC Filing  
3/15/2017Marshall MohrCFOSell4,250$750.00$3,187,500.00View SEC Filing  
3/1/2017Salvatore BrognaEVPSell6,628$736.80$4,883,510.40View SEC Filing  
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Intuitive Surgical (NASDAQ:ISRG)
Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
DateHeadline logoIntuitive Surgical, Inc. (ISRG) EVP Sells $4,052,600.00 in Stock - April 24 at 10:58 PM logoIntuitive Surgical, Inc. (ISRG) Stock Rating Reaffirmed by Wedbush - April 24 at 8:26 PM logoIntuitive Surgical, Inc. (ISRG) VP Jamie Samath Sells 490 Shares - April 24 at 6:24 PM logoIntuitive Surgical Reported Stellar 1Q17 Earnings - April 24 at 5:38 PM logoWhat Drove Intuitive Surgical’s 1Q17 Growth? - April 24 at 5:38 PM logoWhat Analysts Recommend for Intuitive Surgical after 1Q17 Results - April 24 at 5:38 PM logoETFs with exposure to Intuitive Surgical, Inc. : April 24, 2017 - April 24 at 5:38 PM logoIntuitive Surgical, Inc. (ISRG) Upgraded at Zacks Investment Research - April 24 at 4:04 PM logoIntuitive Surgical's (ISRG) "Buy" Rating Reaffirmed at Barclays PLC - April 23 at 1:26 PM logoIntuitive Surgical (ISRG) Earns News Sentiment Score of 0.42 - April 23 at 12:59 PM logoIntuitive Surgical, Inc. (ISRG) Price Target Increased to $835.00 by Analysts at Wedbush - April 23 at 8:39 AM logoIntuitive Surgical's (ISRG) "Buy" Rating Reaffirmed at Citigroup Inc - April 22 at 2:10 PM logoIntuitive Surgical, Inc. (ISRG) Given Outperform Rating at Leerink Swann - April 22 at 9:47 AM logoIntuitive Surgical, Inc. (ISRG) CEO Gary S. Guthart Sells 18,775 Shares - April 21 at 11:02 PM logoPost Earnings Coverage as Intuitive Surgical's Quarterly Revenue Increased 13%; EPS Gained 15% - Yahoo Finance - April 21 at 10:54 PM logo3 Big Stock Charts for Wednesday: Intuitive Surgical, Inc. (ISRG), Abbott Laboratories (ABT) and Huntington ... - - April 21 at 10:54 PM logoWhy Intuitive Surgical, Inc. (ISRG) Stock Is Surging Today - - April 21 at 10:53 PM logoWhy Intuitive Surgical, Inc. (ISRG) Stock Doesn't Offer Risk-Free Growth - - April 21 at 10:53 PM logoIntuitive Surgical, Inc. (ISRG) Director Sells $2,430,360.00 in Stock - April 21 at 8:32 PM logoIntuitive Surgical, Inc. :ISRG-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 - April 21 at 5:53 PM logoWedbush Comments on Intuitive Surgical, Inc.'s FY2019 Earnings (ISRG) - April 21 at 5:35 PM logoIntuitive Surgical: Q1 Solid, Procedures Likely to Slow Ddown - April 21 at 10:36 AM logoPost Earnings Coverage as Intuitive Surgical's Quarterly Revenue Increased 13%; EPS Gained 15% - April 21 at 10:36 AM logoPositive Media Coverage Very Likely to Affect Intuitive Surgical (ISRG) Share Price - April 20 at 8:11 PM logoI Can't Believe Intuitive Surgical, Inc. Just Spent $2 Billion on Stock Buybacks - April 20 at 6:04 PM logoI Can't Believe Intuitive Surgical, Inc. Just Spent $2 Billion on Stock Buybacks - April 20 at 3:52 PM logoBrokers Issue Forecasts for Intuitive Surgical, Inc.'s Q4 2017 Earnings (ISRG) - April 20 at 2:50 PM logoIntuitive Surgical, Inc. (ISRG) Downgraded to "Hold" at Zacks Investment Research - April 20 at 12:59 PM logoWhy Intuitive Surgical, Inc. (ISRG) Stock Doesn’t Offer Risk-Free Growth - April 20 at 11:58 AM logoIntuitive Surgical Inc. (ISRG) Leaped To A New High On Strong Q1 Earnings - April 20 at 11:21 AM logoHere's How Intuitive Surgical Delivered a Blockbuster Quarter - April 20 at 11:21 AM logoHere's How Intuitive Surgical Delivered a Blockbuster Quarter - April 20 at 8:17 AM logoIntuitive Surgical, Inc. (ISRG) Rating Reiterated by BTIG Research - April 20 at 7:21 AM logoIntuitive Surgical's Q1 Gives This Already Bullish Analyst 'Even Higher Confidence' - April 19 at 10:52 PM logoStifel Nicolaus Reiterates Buy Rating for Intuitive Surgical, Inc. (ISRG) - April 19 at 10:34 PM logoIntuitive Surgical's (ISRG) In-Line Rating Reaffirmed at Evercore ISI - April 19 at 9:24 PM logo10-Q: INTUITIVE SURGICAL INC - April 19 at 5:51 PM logoUS STOCKS-S&P 500 flat, IBM pulls Dow lower - April 19 at 5:51 PM logoRobotic Surgeon Maker Launches To Record High On Strong Q1 - April 19 at 5:51 PM logoWhy Intuitive Surgical, Inc. (ISRG) Stock Is Surging Today - April 19 at 4:14 PM logo3 Big Stock Charts for Wednesday: Intuitive Surgical, Inc. (ISRG), Abbott Laboratories (ABT) and Huntington Bancshares Incorporated (HBAN) - April 19 at 12:57 PM logoMoney flow into Intuitive Surgical ripples out to Mazor Robotics; shares up 5% - April 19 at 12:19 PM logoIntuitive Surgical, Inc. (ISRG) PT Raised to $870.00 - April 19 at 11:27 AM logoIntuitive Surgical Inc. (ISRG) Has Jumped To A New High On Q1 Results - April 19 at 11:21 AM logoEdited Transcript of ISRG earnings conference call or presentation 18-Apr-17 8:30pm GMT - April 19 at 11:21 AM logoIntuitive Surgical (ISRG) Beats on Q1 Earnings & Revenues - April 19 at 11:21 AM logoMorning Movers: Morgan Stanley Jumps, Intuitive Surgical Soars, Southwestern Energy Gains - April 19 at 11:21 AM logoIntuitive Surgical: And the Robot for the Win! - April 19 at 11:21 AM logoShares of this surgical robot maker just jumped to an all-time high on better-than-expected earnings - April 19 at 11:21 AM logoZacks Market Edge Highlights: Insulet, Incyte, Intuitive Surgical and Edwards Lifesciences - April 19 at 11:21 AM


Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) issued its earnings results on Tuesday, April, 18th. The company reported $5.09 EPS for the quarter, topping the consensus estimate of $3.97 by $1.12. The business earned $674.20 million during the quarter, compared to the consensus estimate of $664.72 million. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The firm's revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the company earned $4.42 EPS.

When will Intuitive Surgical make its next earnings announcement?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, July, 17th 2017.

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

16 analysts have issued 1 year target prices for Intuitive Surgical's stock. Their forecasts range from $600.00 to $917.00. On average, they expect Intuitive Surgical's share price to reach $793.42 in the next twelve months.

What are analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • 1. According to Zacks Investment Research, "Intuitive Surgical reported stellar first-quarter 2017 results, crushing the Zacks Consensus Estimate on both the counts on the growing adoption of the da Vinci system (a surgical platform) among physicians and overall growth in global procedures. Furthermore, a positive outlook for the coming quarters raises our confidence in the stock. Over the past three months, Intuitive Surgical outperformed the broader industry in terms of price performance. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company." (4/24/2017)
  • 2. Canaccord Genuity analysts commented, "Our checks at the SAGES conference in Houston this week reaffirmed our near-term bullishness about the firm's fundamentals. A year ago coming out of this important trade show, we opined that a robotics revolution was underway in general surgery;our checks at SAGES 2017 suggest the revolution continues ' especially in hernia repair. Given the large opportunity open to robotic surgery ' nearly 1M annual hernia procedures in the U.S. of which nearly 70% are currently performed via an invasive, open surgery ' we discerned escalating enthusiasm from robotic surgeons. In sum, we think ISRG is positioned well to deliver procedure volume growth at or above its current guidance, which calls for 9-12% growth in 2017. On the competitive front, Medtronic looks to be at least a few years out, but seems to be ISRG's most imminent challenger. At an analyst meeting during SAGES yesterday, Medtronic updated its projections for entry into the surgical robotics arena, targeting initial market entry into a few small countries in Europe before the end of F2018 (April '18). Further, Medtronic expects FDA approval, as well as market expansion into larger European markets, during its F2019, with material revenue contributions expected over that timeframe. Meanwhile, we think ISRG (the company and the stock) still has room to run. We maintain our BUY rating and $800 price target." (3/24/2017)
  • 3. JPMorgan Chase & Co. analysts commented, "Over the weekend, we attended the second annual Global Symposium on Robotic Assisted and Minimally Invasive Hernia Repair, which was a gathering of >250 general surgeons in New York. The meeting was positive for Intuitive Surgical (ISRG), as interest in robotic hernia repair has increased since last year, with a number of presentations highlighting both clinical and cost data, while there was broader acknowledgement that robotics is the future for hernia repair (including by ISRG’s Chief Medical Officer, who not surprisingly, spoke positively about potential future adoption, with potential for it to eventually reach 40-50% penetration). Following the conference, along with our recent physician survey (see note here), we are increasingly confident that hernia is a legitimate opportunity for ISRG, and should continue to be a primary driver of sustainable procedure growth over the near to intermediate term." (9/20/2016)

Are investors shorting Intuitive Surgical?

Intuitive Surgical saw a decline in short interest in March. As of March 15th, there was short interest totalling 3,004,011 shares, a decline of 9.8% from the February 28th total of 3,329,507 shares. Based on an average daily trading volume, of 341,008 shares, the short-interest ratio is presently 8.8 days.

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by many different of retail and institutional investors. Top institutional investors include Columbus Circle Investors (0.31%), Chevy Chase Trust Holdings Inc. (0.14%), Manning & Napier Advisors LLC (0.13%), Gateway Investment Advisers LLC (0.10%), Bank of Montreal Can (0.10%) and LGT Capital Partners LTD. (0.08%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Jerome J Mcnamara, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Advisors LLC, Columbus Circle Investors, Nationwide Fund Advisors, Peregrine Capital Management LLC, Bank of Montreal Can, Factory Mutual Insurance Co., Retirement Systems of Alabama and Hudson Valley Investment Advisors Inc. ADV. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Gary S Guthart, George Stalk Jr, Jamie Samath, Lonnie M Smith, Mark J Meltzer, Marshall Mohr and Salvatore Brogna.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was purchased by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Quantitative Systematic Strategies LLC, Rathbone Brothers plc, National Pension Service, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Candriam Luxembourg S.C.A. and Kissinger Financial Services LLC.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Intuitive Surgical stock cost?

One share of Intuitive Surgical stock can currently be purchased for approximately $822.18.

Intuitive Surgical (ISRG) Chart for Monday, April, 24, 2017

This page was last updated on 4/24/2017 by Staff